Stay Ahead of Market & Policy Shifts
Financial & Policy Research Insights
Sector: Healthcare
Revvity: Revitalized for Stronger Growth
Fundamental, Research
Rebranded as Revvity, it aims at becoming a high growth, high margin firm...
Read more
Health Care REITs Poised for Healthy Returns
Fundamental, Video
The aging US population and increasing healthcare expenditures...
Read more[CVS, CI, UNH, ELV]: Entrenchment of PBM Overhang with More Bills Expected
Policy & Legal, Research
No relief for PBMs [CVS (CVS), Cigna (CI),...
Read more
May 2023 PDUFA Calendar
Policy & Legal, Research
Delays in approvals due to disrupted work schedules at FDA because of the coronavirus...
Read moreSilk Road (SILK): Competition & Coverage
Policy & Legal, Research
Amid investor fears of competitive risks to Silk Road Medical’s (SILK)’s TCAR procedure...
Read moreApril 2023 PDUFA Calendar
Policy & Legal, Research
Disrupted work schedules at FDA result in approval delays...
Read more
Advisory Committee’s Split Decision on Biogen’s Tofersen
Policy & Legal, Research
We expect the FDA to grant accelerated approval of Biogen's (BIIB) ALS treatment...
Read moreMitigation Expectations for Medicare Advantage Rate Notice
Policy & Legal, Research
Size of Medicare Advantage mitigation may be less than earlier expectations...
Read more
European Pharma: Top Picks as Growth Slows; New Launches and Core Products are Key
Fundamental, Research
How European Pharma fared versus consensus estimates...
Read more
Glaukos (GKOS): Pipeline Policy Pathway
Policy & Legal, Research
Following Glaukos’ (GKOS) earnings report, attention now turns to the regulatory...
Read more